7-(4-(4-(1H-Tetrazol-5-yl)phenoxy)butyl)-1,3-dimethyl-3,7-dihydro-1H-Purine-2,6-dione

ID: ALA4783087

PubChem CID: 162664714

Max Phase: Preclinical

Molecular Formula: C18H20N8O3

Molecular Weight: 396.41

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1c(=O)c2c(ncn2CCCCOc2ccc(-c3nnn[nH]3)cc2)n(C)c1=O

Standard InChI:  InChI=1S/C18H20N8O3/c1-24-16-14(17(27)25(2)18(24)28)26(11-19-16)9-3-4-10-29-13-7-5-12(6-8-13)15-20-22-23-21-15/h5-8,11H,3-4,9-10H2,1-2H3,(H,20,21,22,23)

Standard InChI Key:  DONHTLJTWLSOHU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   10.0661   -7.9911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9821   -7.1766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1796   -7.0017    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7669   -7.7149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9685   -7.8856    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7138   -8.6629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2617   -9.2735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0642   -9.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3188   -8.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9113   -8.8336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6120   -9.7133    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4206   -7.2751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0070  -10.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7794   -8.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4884   -7.9911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1975   -8.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9066   -7.9911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6198   -8.3997    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3289   -7.9911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0380   -8.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7471   -7.9911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7471   -7.1698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0380   -6.7612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3289   -7.1698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2076   -7.0914    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7555   -6.4850    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3427   -5.7718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5443   -5.9466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4562   -6.7612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
  6 10  2  0
  8 11  2  0
  5 12  1  0
  7 13  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
 18 19  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 25 29  1  0
 22 29  1  0
 17 18  1  0
  1 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4783087

    ---

Associated Targets(Human)

PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 396.41Molecular Weight (Monoisotopic): 396.1658AlogP: 0.47#Rotatable Bonds: 7
Polar Surface Area: 125.51Molecular Species: ACIDHBA: 10HBD: 1
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.33CX Basic pKa: CX LogP: 0.96CX LogD: -0.64
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.45Np Likeness Score: -1.71

References

1. Shekouhy M,Karimian S,Moaddeli A,Faghih Z,Delshad Y,Khalafi-Nezhad A.  (2020)  The synthesis and biological evaluation of nucleobases/tetrazole hybrid compounds: A new class of phosphodiesterase type 3 (PDE3) inhibitors.,  28  (12): [PMID:32503691] [10.1016/j.bmc.2020.115540]

Source